Home / Companies / Company Results /  Natco Pharma Q4 results: Net profit dips 43% to 53 crore

NEW DELHI : Drug firm Natco Pharma on Thursday said its consolidated net profit declined by 43% to 53 crore for the fourth quarter ended March 31, 2021.

The Hyderabad-based company had posted a net profit of 93 crore for the January-March quarter of 2019-20 fiscal.

Total income during the fourth quarter stood at 360 crore, down from 477 crore in the fourth quarter of the financial year 2019-20, the drugmaker said in a regulatory filing.

For the entire 2020-21 fiscal, the company posted a consolidated net profit of 442 crore as compared with 458 crore in 2019-20.

Total income increased to 2,156 crore in the last fiscal from 2,022 crore in the financial year 2019-20.

"In spite of the significant negative impact of the pandemic on the base business, the company was able to sustain its revenue during the year," the drug firm noted.

The company expects strong growth during the current financial year due to multiple high-value product launches in the US, rebound in domestic India business with new products, and contribution from the Crop Health division, it added.

Shares of the company ended 4.43% down at 1,081.15 apiece on BSE on Thursday.

Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.
Recommended For You
Edit Profile
Get alerts on WhatsApp
Set Preferences My ReadsFeedbackRedeem a Gift CardLogout